Cure EB

Funding rounds backed by Cure EB.

Export CSV
Funding disclosed in full
$2.7M
Median round
$2.7M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Healome Therapeutics

Develops proprietary eye-drop matrix technology for ocular surface diseases

£2MSeedBiotechUnited Kingdom
5 participantsCure EBDEBRA ResearchEmpirical VenturesOshen BioSFC Capital